<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mechanisms of pleural liquid accumulation in disease</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mechanisms of pleural liquid accumulation in disease</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Mechanisms of pleural liquid accumulation in disease</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">V Courtney Broaddus, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Talmadge E King, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Geraldine Finlay, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In the normal pleural space, there is a steady state in which there is a roughly equal rate of the formation (entry) and absorption (exit) of liquid (<a class="graphic graphic_figure graphicRef62020" href="/z/d/graphic/62020.html" rel="external">figure 1</a>). This balance must be disturbed in order to produce a pleural effusion [<a href="#rid1">1</a>]. This topic discusses the mechanisms involved in pleural fluid accumulation in pathologic states. Mechanisms that underlie turnover in the normal state are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6692.html" rel="external">"Mechanisms of pleural liquid turnover in the normal state"</a>.)</p><p class="headingAnchor" id="H1579473844"><span class="h1">BACKGROUND</span><span class="headingEndMark"> — </span>To generate a pleural effusion, there must be an increase in entry rate and/or a reduction in exit rate. To generate a clinically relevant effusion, it is likely that <strong>both</strong> mechanisms contribute to effusion formation for the following reasons:</p><p class="bulletIndent1"><span class="glyph">●</span>An <strong>isolated increase in entry rate</strong>, unless large and sustained, is unlikely to cause a clinically significant effusion because the absorbing pleural lymphatics have a large reserve capacity to deal with excess pleural liquid. If, for example, artificial hydrothoraces are instilled into the pleural space of awake sheep, the exit rate can increase to 0.28 mL/kg per hour, which is 28 times the baseline rate [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An <strong>isolated decrease in exit rate</strong> is also unlikely to cause a large effusion because the normal entry rate is low. Even if the exit of liquid ceased entirely, accumulation of liquid would take many days to become evident. As an example, the normal entry rate of 0.01 mL/kg per hour is equivalent to a total of 12 mL/day in a 50 kg woman; at this rate of entry without any exit of liquid, it would take more than one month for 500 mL to accumulate in the pleural space. Of note, the effusion would presumably be a transudate, because the normal liquid entering the pleural space is low in protein.</p><p></p><p class="headingAnchor" id="H2"><span class="h1">INCREASED FLUID ENTRY</span><span class="headingEndMark"> — </span>Factors involved in common clinical scenarios can increase fluid flow into the pleural space. Such factors, described in this section, can include increased venous pressure, decreased pleural pressure, or increased vascular permeability due to inflammation, infection, or malignancy. Normally, liquid filters out of systemic microvessels based on a balance of hydrostatic and osmotic forces across a semipermeable membrane [<a href="#rid3">3,4</a>]. These forces are described in the Starling equation, in which the hydrostatic forces that force water out of the vessel are balanced by osmotic forces that reabsorb water back into the vessel [<a href="#rid5">5,6</a>].</p><div class="formulaContainer"><div class="formula"><p>Flow = <strong>k</strong> x [(<strong>P</strong>mv - <strong>P</strong>pmv) - s (<strong>π</strong>mv - <strong>π</strong>pmv)]</p></div></div><p>In this equation, <strong>k</strong> is liquid conductance of the microvascular barrier, <strong>P</strong>mv and <strong>P</strong>pmv represent hydrostatic pressure in the microvascular and perimicrovascular compartments, s is the reflection coefficient for total protein and ranges from 0 (completely permeable) to 1 (completely impermeable), and <strong>π</strong>mv and <strong>π</strong>pmv represent protein osmotic pressure in microvascular and perimicrovascular liquids, respectively. In normal microvessels, there is ongoing filtration of a small amount of low protein liquid. The flow from the microvessels can increase with changes in various parameters of the Starling equation.</p><p class="headingAnchor" id="H3"><span class="h2">Increase in permeability</span><span class="headingEndMark"> — </span>Increases in permeability of blood vessels result from inflammation, infection, or malignancy, all common causes of pleural effusions. If the endothelial barrier becomes more permeable to liquid and protein, for example, there will be an increase in flow of a higher-protein liquid. Because absorption does not alter the protein concentration of pleural liquid, pleural liquid with a high protein concentration indicates its origin from a circulation across an area of increased permeability. (See  <a class="medical medical_review" href="/z/d/html/6692.html" rel="external">"Mechanisms of pleural liquid turnover in the normal state", section on 'Evidence for bulk flow'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Increase in microvascular pressure</span><span class="headingEndMark"> — </span>As mentioned above, an elevation in microvascular pressure (<strong>P</strong>mv) is usually induced by an elevation in venous pressure. Either systemic or pulmonary venous pressure can lead to increased filtration and increased entry of fluid into the pleural space. Clinical conditions with elevated systemic venous pressure include congestive heart failure with right heart failure, pulmonary embolism, and central venous obstruction. The major clinical condition associated with increased pulmonary venous pressure is congestive heart failure. (Increases in <strong>arterial</strong> pressure are less likely to be transmitted to the microvessels because of the high precapillary resistance and autoregulation of arteriolar tone).</p><p>Elevations in systemic venous pressure alone (which would mostly affect the parietal pleura) would be associated with a greater sieving of proteins, leading to a filtrate with a lower protein concentration than normal (with a pleural liquid-to-serum protein ratio of less than 0.15). Of course, most transudative effusions have a pleural liquid-to-serum protein ratio much higher than this, between 0.4 and 0.5. This fact demonstrates that most liquid must arise from a source other than the systemic circulation of the pleural membranes. The likely source is the large nonsystemic circulation adjacent to the pleural space, namely the pulmonary circulation of the nearby lung. In the normal state, lung interstitial liquid, eg, lymph, filtered from the low-pressure pulmonary circulation has a protein concentration ratio (lung to serum protein concentration ratio) of 0.7, but with increased flow due to increased pulmonary microvascular pressures, this ratio falls to 0.4 to 0.5 [<a href="#rid7">7</a>]. As shown in studies of anesthetized sheep, this lung interstitial edema liquid is the likely source of the majority of the hydrostatic pleural effusion [<a href="#rid8">8</a>].</p><p>How does the lung edema liquid reach the pleural space? When the rate of filtrate formation exceeds the absorptive capacity of the lung lymphatics, the filtrate accumulates in the peribronchovascular spaces ("cuffs") [<a href="#rid9">9</a>]. Once in these interstitial spaces, the liquid is not accessible to lung lymphatics [<a href="#rid10">10</a>]. Thus, although the lymphatics are undeniably important in removing liquid as it is filtered from the pulmonary circulation, they cannot account for the clearance of already established edema from the lung [<a href="#rid11">11</a>]. This interstitial edema probably leaves the lung by flowing in response to pressure gradients along the interstitial spaces (interlobular septae, peribronchovascular bundles and visceral pleura) of the lung toward either the mediastinum or the pleural space. The entry of large amounts of lung interstitial liquid into the pleural space will elevate the overall protein concentration of the pleural liquid, giving a ratio of 0.40-0.50, the expected range for a transudative effusion [<a href="#rid8">8</a>].</p><p>The vast majority of transudative effusions are caused by pulmonary venous pressure elevation due to congestive heart failure and have protein ratios of approximately 0.4. If a transudative effusion has a lower protein concentration, it may be caused by systemic venous pressure elevation, such as by central venous obstruction.</p><p class="headingAnchor" id="H5"><span class="h2">Decrease in pleural pressure</span><span class="headingEndMark"> — </span>Decreased pleural pressure is the likely explanation for the formation of pleural effusions in the setting of atelectasis.</p><p>A decrease in pleural pressure, as seen with significant atelectasis, may alter the balance of forces described in the Starling equation by reducing the pressures surrounding the nearby microvessels. This decrease in perimicrovascular pressures (<strong>P</strong>pmv) can enhance filtration across the microvascular barrier of a low protein liquid (with a pleural liquid-to-serum protein ratio of less than 0.15). Thus, fluid will accumulate until the pressure balance is restored.</p><p class="headingAnchor" id="H6"><span class="h2">Decrease in plasma osmotic pressure</span><span class="headingEndMark"> — </span>While a low albumin or protein concentration may be an infrequent cause of effusions by itself, it may contribute to effusion formation by other causes.</p><p>Hypoproteinemia (due to hypoalbuminemia) will decrease the plasma oncotic pressure (πmv), thereby increasing the forces favoring filtration until the balance is restored. By itself, hypoproteinemia can probably induce small effusions with a low protein concentration. In addition, hypoproteinemia can lower the threshold for effusion formation when other Starling forces are changed. In a study of hospitalized patients with AIDS, for example, hypoproteinemia alone was the apparent cause of 19 percent of all pleural effusions [<a href="#rid12">12</a>]. However, together with other factors, a lower serum protein concentration may have contributed to effusion formation in many more patients because, in general, the patients with effusions had a lower serum albumin concentration than those without effusion (2.5 versus 3.4 g/dL). In another study, hypoalbuminemia may have enhanced the size of pleural effusions, perhaps by shifting the balance toward increased filtration; in children with parapneumonic pleural effusions, those with large effusions had a lower mean serum albumin concentration than those with small effusions (2.7 versus 3.7 g/dL) [<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H7"><span class="h1">DECREASED FLUID EXIT</span><span class="headingEndMark"> — </span>A decrease in exit rate indicates a reduction in clearance of fluid from the pleural space, a clearance that largely takes place via the parietal pleural lymphatics. Because lymphatic function is poorly understood, much of this discussion is speculative. Unlike blood vessels, lymphatic vessels have one-way valves. Lymph is propelled actively by rhythmic muscular contractions of lymphatic smooth muscle and passively by compressions from the respiratory motions of the chest wall. In addition, flow is affected by lymphatic patency, availability of liquid, and the pressures influencing filling (pleural pressure) and emptying (systemic venous pressure) of lymphatics [<a href="#rid14">14,15</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Intrinsic factors</span><span class="headingEndMark"> — </span>A number of factors can interfere with or inhibit the ability of lymphatics to contract, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Cytokines and products of inflammation (eg, endotoxins)</p><p class="bulletIndent1"><span class="glyph">●</span>Endocrine abnormalities (eg, hypothyroidism)</p><p class="bulletIndent1"><span class="glyph">●</span>Injury due to radiation or drugs (eg, chemotherapeutic agents)</p><p class="bulletIndent1"><span class="glyph">●</span>Infiltration of lymphatics by cancer</p><p class="bulletIndent1"><span class="glyph">●</span>Anatomic abnormalities (eg, yellow nail syndrome)</p><p></p><p class="headingAnchor" id="H9"><span class="h2">Extrinsic factors</span><span class="headingEndMark"> — </span>Multiple extrinsic factors can inhibit lymphatic function although the lymphatics themselves are normal. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Limitation of respiratory motion (eg, diaphragm paralysis, lung collapse, pneumothorax)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Mechanical compression of lymphatics (eg, pleural fibrosis, pleural granulomas)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Blockage of lymphatic stomata (eg, fibrin deposition on pleural surface, pleural malignancy)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Decreased intrapleural pressure (eg, atelectasis)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased systemic venous pressure – Acutely, increases in venous pressure may decrease lymphatic flow because of the higher downstream pressures into which the lymphatics empty; chronically, the lymphatics may be able to adapt.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Decreased availability of fluid at the lymphatics – After pneumothorax, for example, fluid may not remain in contact with lymphatic stomata and may accumulate at the dependent portion of the pleural space as a small effusion.</p><p></p><p class="headingAnchor" id="H10"><span class="h1">INTERPLAY OF PATHOGENETIC MECHANISMS IN DISEASE STATES</span><span class="headingEndMark"> — </span>As discussed above, no single mechanism is likely to explain the development of a pleural effusion. It is likely that, for many effusions, multiple factors contribute to effusion formation. In addition, an alteration of one mechanism can lower the threshold for effusion formation later by another mechanism. As an example, a decreased exit rate due to malignant infiltration or fibrosis of lymphatics can gradually reduce the capacity of the lymphatics to drain pleural liquid. As long as the entry rate remains low, an effusion will not form; however, if the entry rate should increase, the limitation of the exit rate would reduce the ability of the lymphatics to handle the increased fluid and an effusion could then accumulate.</p><p>There are some data on the entry and exit rates of pleural liquid in patients with pleural effusions. In two early studies of the turnover of pleural liquid in effusions of patients with a variety of different diseases, the entry rates were highest in tuberculosis but similar among the other disorders [<a href="#rid16">16,17</a>]. The exit rates were low in malignant and tuberculous effusions compared with the rates in effusions due to cardiac failure and pulmonary embolism. In one study, for example, calculated lymphatic flow for patients with pulmonary embolism was 0.18 mL/kg per hour, which is similar to the maximal exit rate measured for sheep (0.28 mL/kg per hour); in comparison, lymphatic flow was lower in the patients with carcinoma or tuberculosis (0.06 and 0.08 mL/kg per hour, respectively), suggesting that a reduced lymphatic capacity contributed to the formation of these effusions [<a href="#rid17">17</a>]. Interestingly, in patients with tuberculous effusions, the entry rate decreased and the exit rate increased after therapy with <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a>.</p><p class="headingAnchor" id="H12"><span class="h2">Pleural disease</span><span class="headingEndMark"> — </span>Direct involvement of pleural membranes by disease can lead to a pleural effusion by increasing the formation of liquid and interfering with parietal pleural lymphatic function (<a class="graphic graphic_figure graphicRef54788" href="/z/d/graphic/54788.html" rel="external">figure 2</a>). Hydrostatic pressure elevations can also increase filtration from the pleural membrane microvessels. For patients with pleural malignancy or tuberculosis, the synergistic combination of increased entry and decreased exit of liquid may explain the massive effusions that can accumulate.</p><p class="headingAnchor" id="H2818753753"><span class="h3">Malignancy</span><span class="headingEndMark"> — </span>Malignant effusions are probably caused by both mechanisms, increased entry plus decreased exit of fluid. There are patients with rapid entry rates, which can be recognized clinically because the effusion accumulates rapidly after drainage or has a high chest tube drainage rate. In this setting, the tumor has presumably extensively infiltrated pleural capillaries, leading to increased filtration, or is producing cytokines, such as vascular endothelial growth factor (VEGF), that increase capillary permeability [<a href="#rid18">18,19</a>]. One study indicated that the mast cell may be the key cell producing cytokines, such as tryptase AB1 and IL1 beta, leading to increased permeability [<a href="#rid20">20</a>]. Decreased plasma osmotic pressure or decreased pleural pressure could contribute to the enhanced entry of liquid.</p><p>On the other hand, malignancy may lead to effusion formation by infiltrating the draining lymphatics or lymph nodes, thereby decreasing the exit rate. In some cases of lymphatic involvement, the decrease in the exit rate appears to be an important mechanism of effusion formation because the effusions can resolve after mediastinal irradiation of involved lymph nodes. In certain malignant effusions, extrapleural involvement of draining lymphatics may be the sole mechanism of effusion formation. Such an isolated exit block may explain the existence of transudative effusions, which have been described in approximately 10 percent of patients with malignant effusions [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H1471545184"><span class="h3">Tuberculosis</span><span class="headingEndMark"> — </span>In tuberculous pleural effusions, the pleural membranes are infiltrated with granulomas, an infiltration that may lead to both an increased entry rate and decreased exit rate of liquid. The high protein concentration of tuberculous pleural effusions indicates its origin from capillaries involved with an intense inflammation [<a href="#rid17">17</a>]. The exit rate, on the other hand, has been found to be low in both patients and animals with experimental models of Bacillus Calmette-Guerin (BCG) pleurisy [<a href="#rid16">16,17,22</a>]. The low exit rate may indicate that inflammation of the parietal pleural by tuberculosis is extensive and intense enough to compromise pleural lymphatic function.</p><p class="headingAnchor" id="H13"><span class="h2">Pleural microvessel hydrostatic pressure elevation</span><span class="headingEndMark"> — </span>An increase in the microvascular pressure of pleural vessels can increase filtration in a variety of ways. Systemic venous pressure elevation both increases filtration from the parietal pleural microvessels and decreases lymphatic drainage into the venous system (<a class="graphic graphic_figure graphicRef76273" href="/z/d/graphic/76273.html" rel="external">figure 3</a>). In comparison, an elevation in pulmonary venous pressure increases filtration from the visceral pleura.</p><p class="headingAnchor" id="H780838633"><span class="h3">Pulmonary embolism</span><span class="headingEndMark"> — </span>Pulmonary embolism can increase entry rates of liquid by injuring pulmonary and adjacent pleural systemic circulations, by elevating hydrostatic pressures in pulmonary veins and/or systemic veins, and perhaps by lowering pleural pressure due to atelectasis. Pulmonary embolism may also decrease exit rates of pleural liquid by increasing the systemic venous pressure (thereby hindering lymphatic drainage) or perhaps by decreasing pleural pressure (thereby hindering lymphatic filling). The observation that all effusions due to pulmonary embolism were exudates suggests a key role for vascular injury [<a href="#rid23">23</a>]; however, hydrostatic pressure changes probably also contribute to the formation of the effusions. One retrospective study comparing patients with PE found that those with effusions were more likely to have more severe PE and pulmonary infarction than those without effusions [<a href="#rid24">24</a>]. As in acute lung injury, when microvessels are injured, small changes in hydrostatic pressure can have a large effect on fluid flux.</p><p class="headingAnchor" id="H1512874359"><span class="h3">Superior vena cava syndrome</span><span class="headingEndMark"> — </span>The mechanism of effusion formation in patients with the superior vena cava syndrome has only been studied in a few cases [<a href="#rid25">25</a>]. Apparently, the entry rate of liquid into the pleural space is increased. The most detailed study has been in one patient who was shown to have a transudative effusion with flow through the thoracostomy tube of approximately 500 mL/day [<a href="#rid26">26</a>]. In another study of volume-loaded dogs, an elevation in systemic venous pressure for two hours plus a decrease in plasma osmotic pressure led to a significant increase in pleural liquid entry and formation of an effusion [<a href="#rid27">27</a>].</p><p>The exit rate may also be decreased acutely since the lymphatics must pump against a higher downstream pressure. With chronic pressure elevations, however, the lymphatics may adapt and resume a more normal capacity. In a series of 27 patients with chronic systemic venous pressure elevation due to pulmonary hypertension, for example, no effusions were found on ultrasonography [<a href="#rid28">28</a>]. More recently, small effusions have been noted to be common in patients with elevated right sided pressures and right heart failure due to idiopathic pulmonary hypertension. It is possible that even these small effusions were generated by the interference of the right heart in left heart function [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H1530982449"><span class="h3">Brachiocephalic venous obstruction</span><span class="headingEndMark"> — </span>This entity has been identified as a cause of persistent, sometimes intractable transudative effusions. In particular, the venous obstruction, often developing in a patient undergoing hemodialysis, is thought to increase pleural microvascular hydrostatic pressure, and thereby increase pleural liquid formation and decrease lymphatic clearance [<a href="#rid30">30</a>]. The effusion can resolve after angioplasty of the occluded vessel [<a href="#rid31">31,32</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Lung</span><span class="headingEndMark"> — </span>The lung is a potentially large source of liquid immediately adjacent to the pleural space. Lung interstitial liquid can move into the pleural space along a pressure gradient and across leaky pleural membranes (<a class="graphic graphic_figure graphicRef71048" href="/z/d/graphic/71048.html" rel="external">figure 4</a>) [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H655875281"><span class="h3">Acute lung injury</span><span class="headingEndMark"> — </span>From animal studies in which injury is limited to the lung, it is clear that large amounts of lung liquid can move into the pleural space. After chemical or hyperoxia-induced lung injury in animals, for example, an increased permeability lung edema developed and was followed by high protein pleural effusions in approximately two hours [<a href="#rid34">34-36</a>]. With hyperoxic lung injury in rats, the movement of liquid from lung to pleural space could be traced by the movement of a specific marker [<a href="#rid37">37</a>]. In sheep given intravenous oleic acid, liquid leaving the lung across the visceral pleura could be collected in a surrounding bag and quantified as representing almost 20 percent of the lung edema [<a href="#rid36">36</a>].</p><p>These observations suggest that pleural effusions should be common in patients with acute lung injury. In a radiographic study of patients with pulmonary edema, for example, pleural effusions were found to be as common in patients with acute lung injury (36 percent) as in patients with hydrostatic pulmonary edema (40 percent) [<a href="#rid38">38</a>]. Other lung injuries, such as pneumonia or pulmonary embolism, can also result in effusion formation due to the movement of high protein lung interstitial liquid into the pleural space.</p><p class="headingAnchor" id="H1024289564"><span class="h3">Hydrostatic pulmonary edema</span><span class="headingEndMark"> — </span>In heart failure, in contrast to lung injury, the abnormalities are not limited to the lung; as a result, identification of the source of the pleural liquid has been more difficult. An elevation in systemic venous and pulmonary venous pressures can lead to increased filtration from both pleural membranes, decreased absorption via pleural lymphatics, and increased filtration into the lung with movement of lung edema into the pleural space.</p><p>Several studies have addressed the contribution of lung edema to transudative pleural effusions in congestive heart failure. In one experimental study in which pressures were elevated in the systemic venous, the pulmonary venous, or both circulations, the most liquid appeared after systemic pressure elevation [<a href="#rid27">27</a>]. However, this study lasted only two hours and lung edema takes at least two hours to accumulate and then to flow to the pleural space [<a href="#rid8">8,34,36</a>]. It is therefore likely that the contribution from the lung was not yet evident. The observation in a clinical study of patients with heart failure that the presence of pleural effusions by ultrasound correlated better with elevated pulmonary venous pressures than with systemic venous pressures is compatible with the importance of a lung contribution [<a href="#rid39">39</a>]. A later study of patients with pulmonary hypertension showed that isolated increases in systemic venous pressure, at least when chronic, did not cause effusion formation [<a href="#rid28">28</a>].</p><p>The contribution of the lung was directly evaluated by studies in anesthetized sheep in which the lung was isolated in an impermeable bag [<a href="#rid8">8</a>]. Lung edema was created by volume loading to elevate the pulmonary capillary wedge pressure by 10, 20, or 30 cmH2O. Liquid began to leak from the lung and, by two hours after stable pressure elevation, the lung liquid flow had reached a steady state. The lung liquid had the same protein concentration as lung lymph and interstitial liquid later harvested from peribronchovascular spaces ("cuffs"). The amount of liquid flowing from the lung could account for the pleural effusions found in other closed-chest volume-loaded sheep. The edema that cleared the lung into the pleural space accounted for almost 23 to 29 percent of all edema formed. Thus, the contribution of the pleural route to edema clearance appears to be similar for hydrostatic edema as it is for the increased permeability edema formed due to acute lung injury [<a href="#rid36">36</a>]. These observations suggest that the pleural route of edema clearance may be an important additional safety factor protecting against alveolar flooding.</p><p>One of the strongest arguments for the contribution of lung edema to transudative effusions in heart failure is that the protein concentration is most similar to that of lung interstitial liquid. As discussed above, liquid derived from increased filtration across systemic vessels would be expected to have a very low protein concentration with a pleura-to-serum protein concentration ratio of less than 0.15. However, transudative effusions have a higher protein concentration ratio (approximately 0.40 to 0.50), similar to the ratio in pulmonary filtrate (eg, in lung lymph) [<a href="#rid8">8</a>].</p><p>The protein concentration of pleural fluid and the pleural/serum protein concentration ratio can increase with acute diuretic therapy, so that a true transudate may yield indices suggestive of an exudate [<a href="#rid40">40-42</a>]. Although not all studies have shown a change from transudative to exudative chemistries following diuresis [<a href="#rid43">43</a>], this phenomenon must be considered when interpreting pleural chemistries in patients following a significant diuresis [<a href="#rid44">44</a>].</p><p class="headingAnchor" id="H15"><span class="h2">Extrapleural or extrapulmonary</span><span class="headingEndMark"> — </span>Excess liquid from any tissue in the body may find its way to the pleural space by passive flow toward the low pressure of the pleural space. Then, once adjacent to the pleural membranes, the excess fluid could move into the pleural space, either via holes or tears in the mediastinal pleura or diaphragm or via direct flow across the permeable pleural membranes.</p><p></p><p class="headingAnchor" id="H1538860672"><span class="h3">Mediastinal inflammation</span><span class="headingEndMark"> — </span>Effusions have been described following mediastinal inflammation due to esophageal variceal sclerotherapy and esophageal perforation. Chyle can also collect in the mediastinum from a break in the thoracic duct and can then decompress by draining into the pleural space, producing a chylothorax (see  <a class="medical medical_review" href="/z/d/html/6696.html" rel="external">"Etiology, clinical presentation, and diagnosis of chylothorax"</a>). Fluid from a pancreatic pseudocyst can also flow via pressure gradients into the mediastinum and then decompress into the pleural space. Usually decompression of the mediastinal collection is achieved when there is flow into one pleural space and thus, these effusions tend to be unilateral.</p><p class="headingAnchor" id="H1821542170"><span class="h3">Peritoneal pathology (via the diaphragm)</span><span class="headingEndMark"> — </span>Liquid can cross the diaphragm by diffusion or by movement across macroscopic holes, either acquired or congenital. Peritoneal liquid can potentially reach the pleural space by diffusion across the two mesothelial layers, a process which would likely be slow. Peritoneal fluid can also move rapidly across the diaphragm through acquired or congenital defects in the diaphragm [<a href="#rid45">45</a>]. The defects apparently form at points of weakness in the muscular webbing of the diaphragm. Based on observations during video-assisted thoracoscopy, the defects have various morphologies from blebs to fenestrations [<a href="#rid46">46</a>]. They may be missed, even on direct inspection of the diaphragm, unless subdiaphragmatic pressure is increased to expand them. Although some have speculated that liquid might cross the diaphragm via lymphatics, there is no evidence for direct lymphatic channels connecting the peritoneal and pleural spaces across the diaphragm [<a href="#rid47">47,48</a>]. In studies in which radiocontrast dye is instilled into the peritoneal space, the dye clearly drains into lymphatics that travel to the mediastinum; no dye enters the pleural space. Therefore, the only likely mechanism for rapid movement of liquid across the diaphragm is through actual defects in the diaphragm [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Increased fluid entry</strong> – Most effusions are likely caused by <strong>both</strong> increased pleural fluid formation and decreased pleural fluid clearance (<a class="graphic graphic_figure graphicRef62020" href="/z/d/graphic/62020.html" rel="external">figure 1</a>). (See <a class="local">'Increased fluid entry'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Increased permeability</strong> – The protein concentration of pleural liquid is a clue to its formation because the protein concentration is not altered by absorption of pleural liquid via lymphatics. (See <a class="local">'Increase in permeability'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Increased microvascular pressure</strong> – Elevations in either systemic venous pressure (affecting the parietal pleura) or pulmonary venous pressure (affecting the visceral pleura) can lead to an increase in pleural liquid formation and the development of a pleural effusion (<a class="graphic graphic_figure graphicRef76273" href="/z/d/graphic/76273.html" rel="external">figure 3</a>). (See <a class="local">'Increase in microvascular pressure'</a> above.)</p><p></p><p class="bulletIndent2">Transudative effusions from heart failure are likely caused by entry of lung edema (lung interstitial fluid) into the pleural space (<a class="graphic graphic_figure graphicRef71048" href="/z/d/graphic/71048.html" rel="external">figure 4</a>). Interstitial edema probably leaves the lung by flowing down pressure gradients along the interstitial spaces of the lung (interlobular septae, peribronchovascular bundles and visceral pleura) toward either the mediastinum or the pleural space. (See <a class="local">'Increase in microvascular pressure'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Decreased pleural pressure</strong> – Decreased pleural pressure is the likely explanation for the formation of pleural effusions in the setting of atelectasis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Decreased osmotic pressure</strong> – Hypoproteinemia (due to hypoalbuminemia) decreases the plasma oncotic pressure, thereby increasing the forces favoring filtration. By itself, hypoproteinemia may result in small effusions but, when other Starling forces are changed (eg, increased central venous pressure), hypoproteinemia lowers the threshold for effusion formation. (See <a class="local">'Decrease in plasma osmotic pressure'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Decreased fluid exit</strong> – A reduction in lymphatic function will decrease the absorption rate of pleural liquid. Impairment in lymphatic function may be caused by intrinsic factors (eg, hypothyroidism, cancer infiltration, yellow nail syndrome) or extrinsic factors (eg, decreased respiratory motion from diaphragmatic paralysis, perilymphatic granulomas or cancer). (See <a class="local">'Decreased fluid exit'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mechanisms in disease states</strong> – No single mechanism likely explains the development of a pleural effusion. It is likely that, for many effusions, multiple factors contribute to effusion formation. Pleural effusions can also form from excess liquid generated anywhere in the body (lungs, mediastinum, abdomen, retroperitoneum) that moves toward the subatmospheric pressure of the pleural space and across the leaky mesothelium or across defects in the diaphragm or mediastinal pleura. (See <a class="local">'Interplay of pathogenetic mechanisms in disease states'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Broaddus VC. Pleural physiology and pathophysiology. In: Murray and Nadel's Textbook of Respiratory Medicine, 7th ed, Elsevier 2021. p.180.</li><li><a class="nounderline abstract_t">Broaddus VC, Wiener-Kronish JP, Berthiaume Y, Staub NC. Removal of pleural liquid and protein by lymphatics in awake sheep. J Appl Physiol (1985) 1988; 64:384.</a></li><li class="breakAll">Staub NC, Wiener-Kronish JP, Albertine KH. Transport through the pleura: physiology of normal liquid and solute exchange in the pleural space, Marcel Dekker, New York 1985.</li><li><a class="nounderline abstract_t">Lai-Fook SJ. Pleural mechanics and fluid exchange. Physiol Rev 2004; 84:385.</a></li><li><a class="nounderline abstract_t">Starling EH. On the Absorption of Fluids from the Connective Tissue Spaces. J Physiol 1896; 19:312.</a></li><li><a class="nounderline abstract_t">Staub NC. Pulmonary edema. Physiol Rev 1974; 54:678.</a></li><li><a class="nounderline abstract_t">Erdmann AJ 3rd, Vaughan TR Jr, Brigham KL, et al. Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep. Circ Res 1975; 37:271.</a></li><li><a class="nounderline abstract_t">Broaddus VC, Wiener-Kronish JP, Staub NC. Clearance of lung edema into the pleural space of volume-loaded anesthetized sheep. J Appl Physiol (1985) 1990; 68:2623.</a></li><li><a class="nounderline abstract_t">Staub NC, Nagano H, Pearce ML. Pulmonary edema in dogs, especially the sequence of fluid accumulation in lungs. J Appl Physiol 1967; 22:227.</a></li><li><a class="nounderline abstract_t">Gee MH, Havill AM. The relationship between pulmonary perivascular cuff fluid and lung lymph in dogs with edema. Microvasc Res 1980; 19:209.</a></li><li><a class="nounderline abstract_t">Mackersie RC, Christensen J, Lewis FR. The role of pulmonary lymphatics in the clearance of hydrostatic pulmonary edema. J Surg Res 1987; 43:495.</a></li><li><a class="nounderline abstract_t">Joseph J, Strange C, Sahn SA. Pleural effusions in hospitalized patients with AIDS. Ann Intern Med 1993; 118:856.</a></li><li><a class="nounderline abstract_t">Prais D, Kuzmenko E, Amir J, Harel L. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia. Pediatrics 2008; 121:e533.</a></li><li><a class="nounderline abstract_t">Quick CM, Venugopal AM, Dongaonkar RM, et al. First-order approximation for the pressure-flow relationship of spontaneously contracting lymphangions. Am J Physiol Heart Circ Physiol 2008; 294:H2144.</a></li><li><a class="nounderline abstract_t">Hosking B, Makinen T. Lymphatic vasculature: a molecular perspective. Bioessays 2007; 29:1192.</a></li><li><a class="nounderline abstract_t">STEWART PB. The rate of formation and lymphatic removal of fluid in pleural effusions. J Clin Invest 1963; 42:258.</a></li><li><a class="nounderline abstract_t">Leckie WJ, Tothill P. Albumin turnover in pleural effusions. Clin Sci 1965; 29:339.</a></li><li><a class="nounderline abstract_t">Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999; 85:178.</a></li><li><a class="nounderline abstract_t">Bradshaw M, Mansfield A, Peikert T. The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion. Curr Oncol Rep 2013; 15:207.</a></li><li><a class="nounderline abstract_t">Giannou AD, Marazioti A, Spella M, et al. Mast cells mediate malignant pleural effusion formation. J Clin Invest 2015; 125:2317.</a></li><li><a class="nounderline abstract_t">Sahn SA. Malignant pleural effusions. Clin Chest Med 1985; 6:113.</a></li><li><a class="nounderline abstract_t">Apicella MA, Allen JC. A physiologic differentiation between delayed and immediate hypersensitivity. J Clin Invest 1969; 48:250.</a></li><li><a class="nounderline abstract_t">Porcel JM, Madroñero AB, Pardina M, et al. Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients. Respirology 2007; 12:234.</a></li><li><a class="nounderline abstract_t">Choi SH, Cha SI, Shin KM, et al. Clinical Relevance of Pleural Effusion in Patients with Pulmonary Embolism. Respiration 2017; 93:271.</a></li><li><a class="nounderline abstract_t">Rice TW. Pleural effusions in superior vena cava syndrome: prevalence, characteristics, and proposed pathophysiology. Curr Opin Pulm Med 2007; 13:324.</a></li><li><a class="nounderline abstract_t">Good JT Jr, Moore JB, Fowler AA, Sahn SA. Superior vena cava syndrome as a cause of pleural effusion. Am Rev Respir Dis 1982; 125:246.</a></li><li><a class="nounderline abstract_t">Mellins RB, Levine OR, Fishman AP. Effect of systemic and pulmonary venous hypertension on pleural and pericardial fluid accumulation. J Appl Physiol 1970; 29:564.</a></li><li><a class="nounderline abstract_t">Wiener-Kronish JP, Goldstein R, Matthay RA, et al. Lack of association of pleural effusion with chronic pulmonary arterial and right atrial hypertension. Chest 1987; 92:967.</a></li><li><a class="nounderline abstract_t">Tang KJ, Robbins IM, Light RW. Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients. Chest 2009; 136:688.</a></li><li><a class="nounderline abstract_t">Wright RS, Quinones-Baldrich WJ, Anders AJ, Danovitch GM. Pleural effusion associated with ipsilateral breast and arm edema as a complication of subclavian vein catheterization and arteriovenous fistula formation for hemodialysis. Chest 1994; 106:950.</a></li><li><a class="nounderline abstract_t">Muthuswamy P, Alausa M, Reilly B. Clinical problem-solving. The effusion that would not go away. N Engl J Med 2001; 345:756.</a></li><li><a class="nounderline abstract_t">Khalil MA, Rabbani MS, Chima NR, et al. Recurrent Brachiocephalic Vein Stenosis as a Cause for Persistent Left-sided Transudative Pleural Effusion in a Hemodialysis Patient. Ann Vasc Surg 2016; 35:208.e9.</a></li><li><a class="nounderline abstract_t">Wiener-Kronish JP, Broaddus VC. Interrelationship of pleural and pulmonary interstitial liquid. Annu Rev Physiol 1993; 55:209.</a></li><li><a class="nounderline abstract_t">RICHTER CP. The physiology and cytology of pulmonary edema and pleural effusion produced in rats by alpha-naphthyl thiourea (ANTU). J Thorac Surg 1952; 23:66.</a></li><li><a class="nounderline abstract_t">Miller KS, Harley RA, Sahn SA. Pleural effusions associated with ethchlorvynol lung injury result from visceral pleural leak. Am Rev Respir Dis 1989; 140:764.</a></li><li><a class="nounderline abstract_t">Wiener-Kronish JP, Broaddus VC, Albertine KH, et al. Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep. J Clin Invest 1988; 82:1422.</a></li><li><a class="nounderline abstract_t">Bernaudin JF, Theven D, Pinchon MC, et al. Protein transfer in hyperoxic induced pleural effusion in the rat. Exp Lung Res 1986; 10:23.</a></li><li><a class="nounderline abstract_t">Aberle DR, Wiener-Kronish JP, Webb WR, Matthay MA. Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 1988; 168:73.</a></li><li><a class="nounderline abstract_t">Wiener-Kronish JP, Matthay MA, Callen PW, et al. Relationship of pleural effusions to pulmonary hemodynamics in patients with congestive heart failure. Am Rev Respir Dis 1985; 132:1253.</a></li><li><a class="nounderline abstract_t">PILLAY VK. TOTAL PROTEINS IN SEROUS FLUIDS IN CARDIAC FAILURE. S Afr Med J 1965; 39:142.</a></li><li><a class="nounderline abstract_t">Chakko SC, Caldwell SH, Sforza PP. Treatment of congestive heart failure. Its effect on pleural fluid chemistry. Chest 1989; 95:798.</a></li><li><a class="nounderline abstract_t">Romero-Candeira S, Fernández C, Martín C, et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110:681.</a></li><li><a class="nounderline abstract_t">Shinto RA, Light RW. Effects of diuresis on the characteristics of pleural fluid in patients with congestive heart failure. Am J Med 1990; 88:230.</a></li><li><a class="nounderline abstract_t">Broaddus VC. Diuresis and transudative effusions--changing the rules of the game. Am J Med 2001; 110:732.</a></li><li><a class="nounderline abstract_t">Lieberman FL, Hidemura R, Peters RL, Reynolds TB. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites. Ann Intern Med 1966; 64:341.</a></li><li><a class="nounderline abstract_t">Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thorac Cardiovasc Surg 2005; 130:141.</a></li><li><a class="nounderline abstract_t">Shinohara H, Kominami R, Taniguchi Y, Yasutaka S. The distribution and morphology of lymphatic vessels on the peritoneal surface of the adult human diaphragm, as revealed by an ink-absorption method. Okajimas Folia Anat Jpn 2003; 79:175.</a></li><li><a class="nounderline abstract_t">Grimaldi A, Moriondo A, Sciacca L, et al. Functional arrangement of rat diaphragmatic initial lymphatic network. Am J Physiol Heart Circ Physiol 2006; 291:H876.</a></li></ol></div><div id="topicVersionRevision">Topic 6701 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Broaddus VC. Pleural physiology and pathophysiology. In: Murray and Nadel's Textbook of Respiratory Medicine, 7th ed, Elsevier 2021. p.180.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3356657" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Removal of pleural liquid and protein by lymphatics in awake sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3356657" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Removal of pleural liquid and protein by lymphatics in awake sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15044678" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Pleural mechanics and fluid exchange.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16992325" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : On the Absorption of Fluids from the Connective Tissue Spaces.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4601625" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1157217" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2384440" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Clearance of lung edema into the pleural space of volume-loaded anesthetized sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6017888" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pulmonary edema in dogs, especially the sequence of fluid accumulation in lungs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7382845" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The relationship between pulmonary perivascular cuff fluid and lung lymph in dogs with edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3695450" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The role of pulmonary lymphatics in the clearance of hydrostatic pulmonary edema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8480960" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pleural effusions in hospitalized patients with AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18310174" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18326809" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : First-order approximation for the pressure-flow relationship of spontaneously contracting lymphangions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18008374" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Lymphatic vasculature: a molecular perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13984113" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The rate of formation and lymphatic removal of fluid in pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5897702" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Albumin turnover in pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9921991" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23568600" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25915587" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Mast cells mediate malignant pleural effusion formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2988851" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Malignant pleural effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4179171" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : A physiologic differentiation between delayed and immediate hypersensitivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17298456" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Analysis of pleural effusions in acute pulmonary embolism: radiological and pleural fluid data from 230 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28196360" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Clinical Relevance of Pleural Effusion in Patients with Pulmonary Embolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17534180" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Pleural effusions in superior vena cava syndrome: prevalence, characteristics, and proposed pathophysiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6978097" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Superior vena cava syndrome as a cause of pleural effusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5474846" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Effect of systemic and pulmonary venous hypertension on pleural and pericardial fluid accumulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3677841" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Lack of association of pleural effusion with chronic pulmonary arterial and right atrial hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19395582" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8082387" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pleural effusion associated with ipsilateral breast and arm edema as a complication of subclavian vein catheterization and arteriovenous fistula formation for hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11547746" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical problem-solving. The effusion that would not go away.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27263809" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Recurrent Brachiocephalic Vein Stenosis as a Cause for Persistent Left-sided Transudative Pleural Effusion in a Hemodialysis Patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8466174" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Interrelationship of pleural and pulmonary interstitial liquid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14909301" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The physiology and cytology of pulmonary edema and pleural effusion produced in rats by alpha-naphthyl thiourea (ANTU).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2782746" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pleural effusions associated with ethchlorvynol lung injury result from visceral pleural leak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3170750" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3948810" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Protein transfer in hyperoxic induced pleural effusion in the rat.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3380985" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3907444" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Relationship of pleural effusions to pulmonary hemodynamics in patients with congestive heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14269826" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : TOTAL PROTEINS IN SEROUS FLUIDS IN CARDIAC FAILURE.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2924609" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Treatment of congestive heart failure. Its effect on pleural fluid chemistry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11403751" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2309739" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Effects of diuresis on the characteristics of pleural fluid in patients with congestive heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11403759" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Diuresis and transudative effusions--changing the rules of the game.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5902279" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15999054" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12776943" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The distribution and morphology of lymphatic vessels on the peritoneal surface of the adult human diaphragm, as revealed by an ink-absorption method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16489104" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Functional arrangement of rat diaphragmatic initial lymphatic network.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
